Psychiatric treatment often relies on trial-and-error prescribing because biological differences between patients are not routinely used to select therapy.
R&D Focus
Offers neuroscience-related medical services
Innovative Solution
Gate Neurosciences is a healthcare company that offers neuroscience-related medical services. The company is developing the next-generation of targeted CNS therapies, leveraging precision medicine approaches to develop breakthrough drugs for psychiatric and neurologic diseases.
Investment Funding
Last Funding Stage
Venture - Series Unknown
Total Funding Amount
41.1M
Last Funding Amount
25.M
Last Funding Date
05-10-2022
Lead Investors
BioCrossroads, Innoviva, Luson Bioventures, Thornapple River Capital
People
Founders
Derek Small
Michael McCully
About
Gate Neurosciences is a healthcare company that offers neuroscience-related medical services. The company is developing the next-generation of targeted CNS therapies, leveraging precision medicine approaches to develop breakthrough drugs for psychiatric and neurologic diseases. It was founded in 2018 and is headquartered in Carmel, IN, USA.
Products
Demo Product or Complete Product?
Development stage
Something missing or incorrect on this page? Help us enrich this information
